<DOC>
	<DOCNO>NCT02125851</DOCNO>
	<brief_summary>The purpose study determine xanthan gum honey base budesonide slurry exhibit comparable mucosal contact time budesonide/sucralose slurry healthy adult subject .</brief_summary>
	<brief_title>Comparison Esophageal Clearance Times Oral Budesonide Preparations</brief_title>
	<detailed_description>This study blind randomize cross trial study , compare one two alternative slurry ( xanthan gum honey ) current standard sucralose slurry subject determine esophageal clearance . A total 24 , 30 healthy adult subject enrol randomized treatment group sequentially number , opaque , seal envelope ( SNOSE ) prepare uninvolved third party . These envelope label numerically `` Subject 1 '' `` Subject 24 '' , randomly contain treatment administer , order . If additional subject recruit , 6 additional SNOSE prepare similar manner . There 4 type envelop prepared- Sucralose-Xanthan Gum , Xanthan Gum-sucralose , Sucralose-Honey Honey-Sucralose . One regimens randomly insert opaque envelope describe previously seal . The envelope give subject enrollment consent , open nuclear medicine pharmacist determine assign preparation compound administer . Subjects randomize 1:1:1:1 ratio use computer program base random number generation . The sucralose slurry consist 10 gram sucralose mixed 4ml 0.5mg/2ml nebulized budesonide solution ( total budesonide dose 1mg ) 1mCi ( 1ml ) Tc99 sulfur colloid total volume approximately 10ml . The honey slurry consist 5ml honey mix 4ml 0.5mg/2ml nebulized budesonide solution ( total budesonide dose 1mg ) 1mCi ( 1ml ) Tc99 sulfur colloid total volume approximately 10ml . The xanthan gum slurry consist 50mg xanthan gum powder mix 4ml 0.5mg/2ml nebulized budesonide solution ( total budesonide dose 1mg ) , along flavor packet cold press crystallized orange flavor 1mCi ( 1ml ) Tc99 sulfur colloid 5ml distilled water total volume approximately 10ml . The study technician , interpret radiologist study coordinator blind type slurry ingest . Each subject ask guess three slurry he/she receive follow consumption slurry . In addition , subject complete hedonic general label magnitude scale ( h-gLMS ) follow consumption slurry . Data collect initial entry ( age , sex , race , height , complete blood cell count ) record data spreadsheet . The first swallow study record time interval ( 1 second interval initial swallow 10 minute elapse ) count tracer esophagus , area curve total esophageal contact time calculate . After 1 hour `` washout '' period two 8 oz glass water ingest second slurry administer data time point collect . This data obtain nuclear medicine department . The individual denote area interest nuclear medicine study ( upper low esophagus ) well obtain , record , calculate clearance eliminate inter-operator variability . This technique validate currently utilized determine esophageal clearance diagnosis achalasia adult utilize camera protocol ( NM 250- Esophageal Transit Study ) . Data result plot quantity tracer remain ( axis ) v time ( x axis ) calculate total Area Under Curve ( amount remain time point sum tracer clear ) . In previous study compare nebulized viscous topical corticosteroid treatment ( Dellon et al , Gastroenterology 2012 ; 143:321-324 ) , mucosal medication contact time measure scintigraphy represent area curve ( AUC ) overall esophagus . The AUC high oral viscous slurry group ( median=48,900 ) compare nebulized/swallowing group ( median=19,200 ) , p=0.005 . The measurement unit , range standard deviation contact time AUCs provide . There also data provide within subject change outcomes . Attempting extrapolate expect variability AUCs study , standard deviation ~29000 oral viscous slurry group ~11400 nebulized/swallowing group would result similar P value . Both theoretical standard deviation ~60 % median . 1 . Assumptions sample size estimation comparison standard oral viscous slurry experimental slurry ) : 1 . The mean AUC oral viscous slurry treatment ( 'standard ' ) 48,900 , standard deviation 29,000 . 2 . For group subject ( xanthan gum honey ) , probability Type I error control Î±=0.05 . 3 . There crossover carryover effect . If study design crossover two separate group study ( one receive standard slurry receive experimental slurry ) , sample 13 subject per group would 80 % power detect difference 24450 AUC ( i.e . 50 % change standard oral viscous slurry ) . Given study design subject measure standard experimental slurry , assume correlation study ( r=0.70 , within subject standard deviation 22,460 ) anticipate sample 12 subject 80 % power detect change 20000 oral viscous slurry experimental slurry ( either honey gum ) . To allow dropout , 30 subject recruit within-subject comparison study . Data Analysis Plan : 1 . Demographic characteristic study group present use mean standard deviation count percentage . 2 . A patient flow diagram present describe recruitment process ( i.e . number subject consent , number withdrawal ) , randomization completion rate . 3 . The primary outcome mucosal medication contact time measure scintigraphy represent area curve ( AUC ) overall esophagus . A secondary outcome number total second 100 % clearance . 4 . Two separate experiment analyze : Comparison xanthan gum budesonide comparison honey budesonide . With AUC dependent variable , repeat measure analysis variance crossover design use compare slurry order test . 5 . Secondary outcome number second clearance taste substance measure gLMS . Repeated measure analysis variance crossover design use compare slurry order test . 6 . Differences AUC taste honey xanthan gum explore use two sample t-test Wilcoxon rank sum test appropriate</detailed_description>
	<mesh_term>Esophagitis</mesh_term>
	<mesh_term>Eosinophilic Esophagitis</mesh_term>
	<mesh_term>Budesonide</mesh_term>
	<criteria>1 . DEERS eligible 2 . Older 18 y/o , without diagnosis Eosinophilic Esophagitis esophageal disease 1 . History EoE , esophageal surgery know achalasia/stricture previously diagnose GERD GER require frequent week treatment . 2 . Peripheral eosinophil count 0.5 X10^3 / mcL . 3 . Pregnancy breastfeed 4 . Previous adverse reaction budesonide , honey , orange .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>March 2014</verification_date>
	<keyword>slurry</keyword>
	<keyword>splenda</keyword>
	<keyword>sucralose</keyword>
	<keyword>budesonide</keyword>
	<keyword>mucosal contact time</keyword>
</DOC>